Open consultations

2 results

  • A1324 - 3-fucosyllactose as a nutritive substance in infant formula products

    FSANZ has assessed an application made by Glycom A/S to permit the voluntary addition of 3-fucosyllactose (3-FL), a human-identical milk oligosaccharide (HiMO) produced using a genetically modified source organism, Escherichia coli K-12 in infant formula products. FSANZ has prepared a draft food regulatory measure. FSANZ has provided public notification and welcomes your submission to assist with consideration of the application. Consultation papers The... More
    Closes 23 July 2025
  • A1328 - Aminopeptidase from Trichoderma reesei as a processing aid

    FSANZ has assessed an application made by made by IFF Australia Pty Ltd (Trading as Danisco Australia Pty Ltd) to permit the use of of an aminopeptidase from a genetically modified strain of Trichoderma reesei, containing the aminopeptidase gene from Aspergillus clavatus, as a processing aid. FSANZ has prepared a draft food regulatory measure. FSANZ has provided public notification and welcomes your submission to assist with consideration of the application. ... More
    Closes 19 August 2025
2 results. Page 1 of 1